References
- AACE Menopause Guidelines Revision Task ForceAmerican Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of menopauseEndocr Pract20061231533716772207
- North American Menopause SocietyEstrogen and progestogen use in peri- and postmenopausal women: July 2008 position statement of The North American Menopause SocietyMenopause20081558460218580541
- National Institutes of HealthNIH state-of-the-science conference statement on management of menopause-related symptomsNIH Consens State Sci Statements200522138
- UtianWHPsychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive reviewHealth Qual Life Outcomes200534716083502
- North American Menopause SocietyTreatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause SocietyMenopause200411113314716179
- WilliamsREKalilaniLDibenedettiDBZhouXFehnelSEClarkRVHealth care seeking and treatment for menopausal symptoms in the United StatesMaturitas20075834835817964093
- FreedmanRRKrellWReduced thermoregulatory null zone in postmenopausal women with hot flashesAm J Obstet Gynecol1999181667010411797
- UtianWHBiosynthesis and physiologic effects of estrogen and pathophysiologic effects of estrogen deficiency: a reviewAm J Obstet Gynecol1989161182818312690634
- MacKayHTTierneyLMMcPheeSJPapadakisMAGynecologyCurrent Medical Diagnosis and TreatmentSan Francisco, CALange Medical Books/McGraw-Hill2004726
- CrandallCJCrawfordSLGoldEBVasomotor symptom prevalence is associated with polymorphisms in sex steroid-metabolizing enzymes and receptorsAm J Med20061199 suppl 1S52S6016949389
- American College of Obstetricians and Gynecologists Women’s Health Care PhysiciansVasomotor symptomsObstet Gynecol20041044 suppl106S117S15458941
- MacLennanAHBroadbentJLLesterSMooreVOral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushesCochrane Database Syst Rev20044CD00297815495039
- NelsonHDCommonly used types of postmenopausal estrogen for treatment of hot flashes: scientific reviewJAMA20042911610162015069049
- Product Information: EVAMIST™ transdermal spray, estradiol transdermal sprayVivus, IncMountain View, CA2007
- KuhlHPharmacology of estrogens and progestogens: influence of different routes of administrationClimacteric20058 Suppl 136316112947
- MinkinMJConsiderations in the choice of oral vs transdermal hormone therapy: a reviewJ Reprod Med20044931132015134159
- RozenbaumHBirkhäuserMDe NooyerCComparison of two estradiol transdermal systems (Oesclim 50 and Estraderm TTS 50). I. Tolerability, adhesion, and efficacyMaturitas1996251611738981333
- RozenbaumHBirkhäuserMDe NooyerCComparison of two estradiol transdermal systems (Oesclim 50 and Estraderm TTS 50). II. Local skin tolerabilityMaturitas1996251751858981334
- FrenkelYKopernikGLazerSAcceptability and skin reactions to transdermal estrogen replacement therapy in relation to climateMaturitas19942031367877518
- BusterJEKoltunWDPascualMLGDayWWPetersonCLow- dose estradiol spray to treat vasomotor symptomsObstet Gynecol20081111343135118515518
- SchumacherRJGattermeirDJPetersonCAWisdomCDayWWThe effects of skin-to-skin contact, application site washing, and sunscreen use on the pharmacokinetics of estradiol from a metered-dose transdermal sprayMenopause20091617718318779758
- SimonJAEstradiol in micellar nanoparticles: the efficacy and safety of a novel transdermal drug-delivery technology in the management of moderate to severe vasomotor symptomsMenopause20061322223116645536
- TaylorMBGutierrezMJAbsorption, bioavailability, and partner transfer of estradiol from a topical emulsionPharmaco Therapy200828712718